Clearmind MedicineCMND

13F holders, Q1 2024 (March 31)
4holders
$1.14avg. 13F price*

At the end of Q1 2024, 4 institutions reported holding Clearmind Medicine Inc. (CMND) in their 13F filings. The largest holders were AdvisorShares Investments LLC ($128K), Susquehanna International Group, LLP ($27K) and Geode Capital Management, LLC ($19K).

Company
Clearmind Medicine Inc.
CUSIP
185053402
Latest filing quarter
Q3 2025

History

Number of 13F holders

0246810 Q1 2024: 4Q1 2024Q2 2024: 4Q2 2024Q3 2024: 8Q3 2024Q4 2024: 9Q4 2024Q1 2025: 7Q1 2025Q2 2025: 9Q2 2025Q3 2025: 7Q3 2025

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions3$47K
Exits0$0

Ownership 4 holders

AdvisorShares Investments LLC 0.02% Add +21.6% 112,693 $128K
Susquehanna International Group, LLP 0.00% New 23,981 $27K
Geode Capital Management, LLC 0.00% New 16,234 $19K
Royal Bank of Canada 0.00% New 569 $1K

"% of holder's portfolio" is CMND's weight in each manager's 13F, not the share of Clearmind Medicine Inc. the manager owns.